ペン型注入器の世界市場 2024-2028

ペン型注入器市場は、2023-2028年に255億1,000万米ドル、予測期間中のCAGRは8.13%で成長すると予測されます。

当レポートでは、ペン型注入器市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。慢性疾患の有病率の上昇、糖尿病患者の増加、注射療法の人気の高まりが市場を牽引しています。

当レポートでは、今後数年間のペン型注入器市場成長を牽引する主要因の1つとして、インスリンペンの大幅な需要増を挙げています。また、ベンダーによるペン型注入器の製品上市の増加や、新製品の商業認可の増加が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界のペン型注入器市場 2018-2022
• 製品別セグメント分析 2018-2022
• 種類別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：製品別

• 市場セグメント
• 比較：製品別
• 成長ホルモン：市場規模と予測 2023-2028
• 糖尿病：市場規模と予測 2023-2028
• 受胎能力：市場規模と予測 2023-2028
• 骨粗鬆症：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：製品別

第7章 市場セグメンテーション：種類別

• 市場セグメント
• 比較：種類別
• 使い捨て式ペン型注入器：市場規模と予測 2023-2028
• 再利用式ペン型注入器：市場規模と予測 2023-2028
• 市場機会：種類別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• カナダ：市場規模と予測 2023-2028
• ドイツ：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因・課題・動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AstraZeneca Plc
• Becton Dickinson and Co.
• Biocon Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• Gerresheimer AG
• GlaxoSmithKline Plc
• Merck KGaA
• Novartis AG
• Novo Nordisk AS
• Owen Mumford Ltd.
• Pfizer Inc.
• Sanofi
• Viatris Inc.
• Ypsomed Holding AG

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
• Exhibits19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Product - Market share 2023-2028 (%)
• Exhibits31: Data Table on Product - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibits35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibits36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibits39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibits40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibits43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibits44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibits47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibits48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
• Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits54: Market opportunity by Product ($ billion)
• Exhibits55: Data Table on Market opportunity by Product ($ billion)
• Exhibits56: Chart on Type - Market share 2023-2028 (%)
• Exhibits57: Data Table on Type - Market share 2023-2028 (%)
• Exhibits58: Chart on Comparison by Type
• Exhibits59: Data Table on Comparison by Type
• Exhibits60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibits61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibits62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibits65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibits66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Type ($ billion)
• Exhibits69: Data Table on Market opportunity by Type ($ billion)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibits109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity By Geographical Landscape ($ billion)
• Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: AstraZeneca Plc - Overview
• Exhibits120: AstraZeneca Plc - Product / Service
• Exhibits121: AstraZeneca Plc - Key news
• Exhibits122: AstraZeneca Plc - Key offerings
• Exhibits123: Becton Dickinson and Co. - Overview
• Exhibits124: Becton Dickinson and Co. - Business segments
• Exhibits125: Becton Dickinson and Co. - Key news
• Exhibits126: Becton Dickinson and Co. - Key offerings
• Exhibits127: Becton Dickinson and Co. - Segment focus
• Exhibits128: Biocon Ltd. - Overview
• Exhibits129: Biocon Ltd. - Business segments
• Exhibits130: Biocon Ltd. - Key offerings
• Exhibits131: Biocon Ltd. - Segment focus
• Exhibits132: Eli Lilly and Co. - Overview
• Exhibits133: Eli Lilly and Co. - Product / Service
• Exhibits134: Eli Lilly and Co. - Key news
• Exhibits135: Eli Lilly and Co. - Key offerings
• Exhibits136: F. Hoffmann La Roche Ltd. - Overview
• Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits138: F. Hoffmann La Roche Ltd. - Key news
• Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits141: Gerresheimer AG - Overview
• Exhibits142: Gerresheimer AG - Business segments
• Exhibits143: Gerresheimer AG - Key news
• Exhibits144: Gerresheimer AG - Key offerings
• Exhibits145: Gerresheimer AG - Segment focus
• Exhibits146: GlaxoSmithKline Plc - Overview
• Exhibits147: GlaxoSmithKline Plc - Business segments
• Exhibits148: GlaxoSmithKline Plc - Key news
• Exhibits149: GlaxoSmithKline Plc - Key offerings
• Exhibits150: GlaxoSmithKline Plc - Segment focus
• Exhibits151: Merck KGaA - Overview
• Exhibits152: Merck KGaA - Business segments
• Exhibits153: Merck KGaA - Key news
• Exhibits154: Merck KGaA - Key offerings
• Exhibits155: Merck KGaA - Segment focus
• Exhibits156: Novartis AG - Overview
• Exhibits157: Novartis AG - Business segments
• Exhibits158: Novartis AG - Key offerings
• Exhibits159: Novartis AG - Segment focus
• Exhibits160: Novo Nordisk AS - Overview
• Exhibits161: Novo Nordisk AS - Business segments
• Exhibits162: Novo Nordisk AS - Key offerings
• Exhibits163: Novo Nordisk AS - Segment focus
• Exhibits164: Owen Mumford Ltd. - Overview
• Exhibits165: Owen Mumford Ltd. - Product / Service
• Exhibits166: Owen Mumford Ltd. - Key offerings
• Exhibits167: Pfizer Inc. - Overview
• Exhibits168: Pfizer Inc. - Product / Service
• Exhibits169: Pfizer Inc. - Key news
• Exhibits170: Pfizer Inc. - Key offerings
• Exhibits171: Sanofi - Overview
• Exhibits172: Sanofi - Business segments
• Exhibits173: Sanofi - Key news
• Exhibits174: Sanofi - Key offerings
• Exhibits175: Sanofi - Segment focus
• Exhibits176: Viatris Inc. - Overview
• Exhibits177: Viatris Inc. - Business segments
• Exhibits178: Viatris Inc. - Key news
• Exhibits179: Viatris Inc. - Key offerings
• Exhibits180: Viatris Inc. - Segment focus
• Exhibits181: Ypsomed Holding AG - Overview
• Exhibits182: Ypsomed Holding AG - Business segments
• Exhibits183: Ypsomed Holding AG - Key offerings
• Exhibits184: Ypsomed Holding AG - Segment focus
• Exhibits185: Inclusions checklist
• Exhibits186: Exclusions checklist
• Exhibits187: Currency conversion rates for US$
• Exhibits188: Research methodology
• Exhibits189: Validation techniques employed for market sizing
• Exhibits190: Information sources
• Exhibits191: List of abbreviations

The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.

Technavio's injection pen market is segmented as below:

By Product

• Growth hormone
• Diabetes
• Fertility
• Osteoporosis
• Others

By Type

• Disposable injection pen
• Reusable injection pen

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the significant rise in demand for insulin pens as one of the prime reasons driving the injection pen market growth during the next few years. Also, increasing injection pen product launches by market vendors and rise in commercial approvals of new products will lead to sizable demand in the market.

The report on the injection pen market covers the following areas:

• Injection pen market sizing
• Injection pen market forecast
• Injection pen market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading injection pen market vendors that include AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG. Also, the injection pen market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global injection pen market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global injection pen market 2018 - 2022 ($ billion)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
• 4.3 Type Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Growth hormone - Market size and forecast 2023-2028
• Exhibit 34: Chart on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibit 35: Data Table on Growth hormone - Market size and forecast 2023-2028 ($ billion)
• Exhibit 36: Chart on Growth hormone - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Growth hormone - Year-over-year growth 2023-2028 (%)
• 6.4 Diabetes - Market size and forecast 2023-2028
• Exhibit 38: Chart on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 39: Data Table on Diabetes - Market size and forecast 2023-2028 ($ billion)
• Exhibit 40: Chart on Diabetes - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Diabetes - Year-over-year growth 2023-2028 (%)
• 6.5 Fertility - Market size and forecast 2023-2028
• Exhibit 42: Chart on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibit 43: Data Table on Fertility - Market size and forecast 2023-2028 ($ billion)
• Exhibit 44: Chart on Fertility - Year-over-year growth 2023-2028 (%)
• Exhibit 45: Data Table on Fertility - Year-over-year growth 2023-2028 (%)
• 6.6 Osteoporosis - Market size and forecast 2023-2028
• Exhibit 46: Chart on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 47: Data Table on Osteoporosis - Market size and forecast 2023-2028 ($ billion)
• Exhibit 48: Chart on Osteoporosis - Year-over-year growth 2023-2028 (%)
• Exhibit 49: Data Table on Osteoporosis - Year-over-year growth 2023-2028 (%)
• 6.7 Others - Market size and forecast 2023-2028
• Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
• Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)
• Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 56: Chart on Type - Market share 2023-2028 (%)
• Exhibit 57: Data Table on Type - Market share 2023-2028 (%)
• 7.2 Comparison by Type
• Exhibit 58: Chart on Comparison by Type
• Exhibit 59: Data Table on Comparison by Type
• 7.3 Disposable injection pen - Market size and forecast 2023-2028
• Exhibit 60: Chart on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 61: Data Table on Disposable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 62: Chart on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Disposable injection pen - Year-over-year growth 2023-2028 (%)
• 7.4 Reusable injection pen - Market size and forecast 2023-2028
• Exhibit 64: Chart on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 65: Data Table on Reusable injection pen - Market size and forecast 2023-2028 ($ billion)
• Exhibit 66: Chart on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• Exhibit 67: Data Table on Reusable injection pen - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Type
• Exhibit 68: Market opportunity by Type ($ billion)
• Exhibit 69: Data Table on Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 73: Chart on Geographic comparison
• Exhibit 74: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
• Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
• Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
• Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ billion)
• Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
• Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
• Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
• Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
• Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 UK - Market size and forecast 2023-2028
• Exhibit 107: Chart on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 108: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
• Exhibit 109: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 110: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 111: Market opportunity By Geographical Landscape ($ billion)
• Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 113: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 115: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 116: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 117: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 118: Matrix on vendor position and classification
• 12.3 AstraZeneca Plc
• Exhibit 119: AstraZeneca Plc - Overview
• Exhibit 120: AstraZeneca Plc - Product / Service
• Exhibit 121: AstraZeneca Plc - Key news
• Exhibit 122: AstraZeneca Plc - Key offerings
• 12.4 Becton Dickinson and Co.
• Exhibit 123: Becton Dickinson and Co. - Overview
• Exhibit 124: Becton Dickinson and Co. - Business segments
• Exhibit 125: Becton Dickinson and Co. - Key news
• Exhibit 126: Becton Dickinson and Co. - Key offerings
• Exhibit 127: Becton Dickinson and Co. - Segment focus
• 12.5 Biocon Ltd.
• Exhibit 128: Biocon Ltd. - Overview
• Exhibit 129: Biocon Ltd. - Business segments
• Exhibit 130: Biocon Ltd. - Key offerings
• Exhibit 131: Biocon Ltd. - Segment focus
• 12.6 Eli Lilly and Co.
• Exhibit 132: Eli Lilly and Co. - Overview
• Exhibit 133: Eli Lilly and Co. - Product / Service
• Exhibit 134: Eli Lilly and Co. - Key news
• Exhibit 135: Eli Lilly and Co. - Key offerings
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Gerresheimer AG
• Exhibit 141: Gerresheimer AG - Overview
• Exhibit 142: Gerresheimer AG - Business segments
• Exhibit 143: Gerresheimer AG - Key news
• Exhibit 144: Gerresheimer AG - Key offerings
• Exhibit 145: Gerresheimer AG - Segment focus
• 12.9 GlaxoSmithKline Plc
• Exhibit 146: GlaxoSmithKline Plc - Overview
• Exhibit 147: GlaxoSmithKline Plc - Business segments
• Exhibit 148: GlaxoSmithKline Plc - Key news
• Exhibit 149: GlaxoSmithKline Plc - Key offerings
• Exhibit 150: GlaxoSmithKline Plc - Segment focus
• 12.10 Merck KGaA
• Exhibit 151: Merck KGaA - Overview
• Exhibit 152: Merck KGaA - Business segments
• Exhibit 153: Merck KGaA - Key news
• Exhibit 154: Merck KGaA - Key offerings
• Exhibit 155: Merck KGaA - Segment focus
• 12.11 Novartis AG
• Exhibit 156: Novartis AG - Overview
• Exhibit 157: Novartis AG - Business segments
• Exhibit 158: Novartis AG - Key offerings
• Exhibit 159: Novartis AG - Segment focus
• 12.12 Novo Nordisk AS
• Exhibit 160: Novo Nordisk AS - Overview
• Exhibit 161: Novo Nordisk AS - Business segments
• Exhibit 162: Novo Nordisk AS - Key offerings
• Exhibit 163: Novo Nordisk AS - Segment focus
• 12.13 Owen Mumford Ltd.
• Exhibit 164: Owen Mumford Ltd. - Overview
• Exhibit 165: Owen Mumford Ltd. - Product / Service
• Exhibit 166: Owen Mumford Ltd. - Key offerings
• 12.14 Pfizer Inc.
• Exhibit 167: Pfizer Inc. - Overview
• Exhibit 168: Pfizer Inc. - Product / Service
• Exhibit 169: Pfizer Inc. - Key news
• Exhibit 170: Pfizer Inc. - Key offerings
• 12.15 Sanofi
• Exhibit 171: Sanofi - Overview
• Exhibit 172: Sanofi - Business segments
• Exhibit 173: Sanofi - Key news
• Exhibit 174: Sanofi - Key offerings
• Exhibit 175: Sanofi - Segment focus
• 12.16 Viatris Inc.
• Exhibit 176: Viatris Inc. - Overview
• Exhibit 177: Viatris Inc. - Business segments
• Exhibit 178: Viatris Inc. - Key news
• Exhibit 179: Viatris Inc. - Key offerings
• Exhibit 180: Viatris Inc. - Segment focus
• 12.17 Ypsomed Holding AG
• Exhibit 181: Ypsomed Holding AG - Overview
• Exhibit 182: Ypsomed Holding AG - Business segments
• Exhibit 183: Ypsomed Holding AG - Key offerings
• Exhibit 184: Ypsomed Holding AG - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 185: Inclusions checklist
• Exhibit 186: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 187: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 188: Research methodology
• Exhibit 189: Validation techniques employed for market sizing
• Exhibit 190: Information sources
• 13.5 List of abbreviations
• Exhibit 191: List of abbreviations